产品名称
Anti-Adenine Nucleotide Translocase-1 (Ab-1) (2-11) Rabbit pAb, liquid, Calbiochem®
biological source
rabbit
antibody product type
primary antibodies
clone
polyclonal
form
liquid
does not contain
preservative
species reactivity
human
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
avoid repeated freeze/thaw cycles
isotype
IgG
shipped in
dry ice
storage temp.
−20°C
Analysis Note
Positive Control
doxorubicin-treated MCF7 cells, or breast carcinoma tissue
doxorubicin-treated MCF7 cells, or breast carcinoma tissue
Application
Immunoblotting (2.5 g/ml, chemiluminescence)
Immunofluorescence (1 g/ml)
Paraffin Sections (1 g/ml, heat pre-treatment required)
Disclaimer
Toxicity: Standard Handling (A)
General description
Anti-Adenine Nucleotide Translocase-1 (Ab-1) (2-11), rabbit polyclonal, recognizes ~35 kDa ANT-1 in doxorubicin-treated MCF-7 cells. It is validated for WB, immunofluorescence, and paraffin sections.
Purified rabbit polyclonal antibody. Recognizes the ~35 kDa ANT-1 protein.
Recognizes the ~35 kDa ANT-1 protein in doxorubicin-treated MCF-7 cells or breast carcinoma tissue.
- Antibody Target Gene Symbol: ANK3
- Target Synonym: 2900054D09RIK, AI314020, AnkG, Ankyrin-3, ANKYRIN-G, FLJ45464, MGC14049
- Entrez Gene Name: ankyrin 3, node of Ranvier (ankyrin G)
- Hu Entrez ID: 288 (Related Antibodies: NB20, AP1034, PC523, AP1057)
- Mu Entrez ID: 11735
- Rat Entrez ID: 361833
Immunogen
Human
a synthetic peptide corresponding to amino acids 2-11 of human ANT-1
Other Notes
Bauer, M.K.A., et al. 1999. J. Cell Biol.147, 1493.
Marzo, I, et al. 1998. Science281, 2027.
Marzo, I, et al. 1998. J. Exp. Med.187, 1261.
Zoratti, M. and Szabo, I. 1995. Biochim. Biophys. Acta1231, 139.
Klingenberg, M. 1993. J. Bioenerg. Biomembr.25, 447.
Riccio, P., et al. 1975. FEBS Lett.56, 133.
Marzo, I, et al. 1998. Science281, 2027.
Marzo, I, et al. 1998. J. Exp. Med.187, 1261.
Zoratti, M. and Szabo, I. 1995. Biochim. Biophys. Acta1231, 139.
Klingenberg, M. 1993. J. Bioenerg. Biomembr.25, 447.
Riccio, P., et al. 1975. FEBS Lett.56, 133.
MCF7 cells treated with doxorubicin at 0.2 µg/ml for 24 h can be used as positive control for immunoblotting. Antibody should be titrated for optimal results in individual systems.
Packaging
Please refer to vial label for lot-specific concentration.
Physical form
In 50 mM sodium phosphate buffer, 50% glycerol.
Preparation Note
Following initial thaw, aliquot and freeze (-20°C).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持